PRSS22 and cancer: Subsequently, we selected 55 pairs of clinical samples for RT-qPCR (Figure 6B), Western blotting (Figure 6C, Supplementary Figure 3) and IHC (Figure 6D), which confirmed the upregulation of PRSS22 expression in cancer tissues at both the mRNA and protein levels.